Table of Content


Introduction
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Overview
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Therapeutics Development
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Therapeutics Assessment
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Companies Involved in Therapeutics Development
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Drug Profiles
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Dormant Projects
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Discontinued Products
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Top 10 Routes of Administration, H1 2020
Number of Products by Stage and Top 10 Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020


List of Tables


Number of Products under Development for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by ArmaGen Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by BioStrategies LC, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by bluebird bio Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by EdiGene Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Eloxx Pharmaceuticals Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by GT Gain Therapeutics SA, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Immusoft Corp, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by JCR Pharmaceuticals Co Ltd, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Jupiter Orphan Therapeutics Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Magenta Therapeutics Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Orchard Therapeutics Plc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Ossianix Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by RegenxBio Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by ReqMed Co Ltd, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Sangamo Therapeutics Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Sigilon Therapeutics Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Tamid Bio Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline by Tega Therapeutics Inc, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Dormant Projects, H1 2020
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Discontinued Products, H1 2020